Detalhe da pesquisa
1.
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
BMC Cancer
; 18(1): 598, 2018 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29801465
2.
Nutritional status of COPD patients with acute exacerbation.
Tuberk Toraks
; 51(3): 239-43, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-15143400
3.
Vascular events in lung cancer.
Asian Pac J Cancer Prev
; 12(10): 2685-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22320975
4.
Comprehensive out-patient pulmonary rehabilitation: Treatment outcomes in early and late stages of chronic obstructive pulmonary disease.
Ann Thorac Med
; 6(2): 70-6, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21572695
5.
Short-term effect of nasal intermittent positive-pressure ventilation in patients with restrictive thoracic disease.
Respiration
; 69(4): 303-8, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12169741